Key result
BIN1 knockdown using AAV9 packaged shRNA-mBIN1 restored ryanodine receptor distribution, recovered Ca2+ transient amplitudes, and rejuvenated cardiac systolic function in 24-month-old mice.
Why the study?
Cardiac dysfunction is a hallmark of aging in humans and mice, prompting investigation into therapeutic strategies to rejuvenate the aging myocardium.
Does BIN1 knockdown improve cardiac systolic function in 24-month-old mice?
Does BIN1 knockdown improve cardiac systolic function in 24-month-old mice?
BIN1 knockdown using AAV9-shRNA-mBIN1 represents a potential novel therapeutic strategy to rejuvenate the aging myocardium and restore systolic function.
BIN1 knockdown restores systolic function in aged mice; hypothesis-generating for BIN1-targeted therapy in human cardiac aging.
Cardiac dysfunction is a hallmark of aging in humans and mice. Here we report that a two-week treatment to restore youthful Bridging Integrator 1 (BIN1) levels in the hearts of 24-month-old mice rejuvenated cardiac function and substantially reversed the aging phenotype. Our data indicate that age-associated overexpression of BIN1 occurs alongside dysregulated endosomal recycling and disrupted trafficking of cardiac Ca V 1.2 and type 2 ryanodine receptors. These deficiencies affect channel function at rest and their upregulation during acute stress. In vivo echocardiography revealed reduced systolic function in old mice. BIN1 knockdown using an adeno-associated virus serotype 9 packaged shRNA-mBIN1 restored the nanoscale distribution and clustering plasticity of ryanodine receptors and recovered Ca 2+ transient amplitudes and cardiac systolic function toward youthful levels. Enhanced systolic function correlated with increased phosphorylation of the myofilament protein cardiac myosin binding protein-C. These results reveal BIN1 knockdown as a novel therapeutic strategy to rejuvenate the aging myocardium.
No takes yet. Share an insight, caveat, or question.
Westhoff et al. (2022) studied Cardiac dysfunction in aging. BIN1 knockdown using AAV9 packaged shRNA-mBIN1 was evaluated on Cardiac systolic function and Ca2+ transient amplitudes. BIN1 knockdown using AAV9 packaged shRNA-mBIN1 restored ryanodine receptor distribution, recovered Ca2+ transient amplitudes, and rejuvenated cardiac systolic function in 24-month-old mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: